Follow us on:

A Blood MOT has never been easier to prevent heart disease (Interview)

Goodbody Health Inc. (AQSE:GDBY) Director George Thomas joins DirectorsTalk Interviews to discuss Blood MOT’s.

February is widely known as ‘heart month’ in the UK, America, Canada amongst other countries. The British Heart Foundation (BHF) says its an important time to bring various heart conditions to the fore and the need for regular screening.

George shares his thoughts on whether people are taking heart health seriously enough, if they need to be more proactive in managing their heart health, what a blood MOT consist of and the experience Goodbody Health has built-up in blood testing.

Goodbody Health Inc. (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: SCNNF) are a wellness company, focusing on the Health and Wellness of customers through the local community by the introduction and use of cutting edge diagnostic equipment.

Disrupting the ‘old model’ of courier to laboratory style testing.

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Goodbody supports NHS health crusade with cholesterol tests February 15, 2022
Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY) February 14, 2022
Goodbody Health to help prevent type 2 diabetes through blood glucose level checks February 10, 2022
Blood testing opens up market for early Cancer detection February 8, 2022
Goodbody Health putting quality and compliance first with extension of scope of ISO 17025 February 7, 2022
Goodbody Health to seize upon £690 million legal UK CBD market February 3, 2022
Goodbody Health aligned with NICE innovation agenda February 2, 2022
Goodbody Health perfectly aligned with NHS Long Term Plan January 31, 2022
Goodbody Health ISIN and SEDOL to be changed on 1st February 2022 January 31, 2022
Why getting your prostate checked is so important January 26, 2022

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.